Keywords: fda, panel, supports, safety, biologicals, rheumatoid, arthritis

FDA panel supports safety of biologicals in rheumatoid arthritis

Article | 10 March 2003

Print This

A US Food and Drug Administration advisory panel has come out in supportof the use of the new tumor necrosis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in